NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)

被引：0

作者：

Guirado, M. ^{[1
]}

Majem, M. ^{[2
]}

Massuti Sureda, B. ^{[3
]}

de las Penas Bataller, R. ^{[4
]}

Ortega Granados, A. L. ^{[5
]}

Isla Casado, M. D. ^{[6
]}

Domine Gomez, M. ^{[7
]}

Marse Fabregat, R. ^{[8
]}

Sala, M. A. ^{[9
]}

Paredes Lario, A. ^{[10
]}

Moran Bueno, M. T. ^{[11
]}

Vazquez Estevez, S. ^{[12
]}

Coves Sarto, J. ^{[13
]}

Gonzalez-Larriba, J. L. ^{[14
]}

Sanchez Torres, J. M. ^{[15
]}

Vicente, D. ^{[16
]}

Farre Bernado, N. ^{[17
]}

Fernandez-Fornos, L. ^{[18
]}

Varcarcel, F. ^{[19
]}

Provencio, M. ^{[20
]}

机构：

[1] Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain

[2] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain

[3] Hosp Gen Univ Alicante, Dept Med Oncol, Alicante, Spain

[4] Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain

[5] Univ Jaen, Complejo Hosp Jaen, Oncol Med, Jaen, Spain

[6] Hosp Clin Univ Lozano Blesa, Dept Med Oncol, Zaragoza, Spain

[7] Univ Hosp Fdn Jimenez Diaz, Dept Med Oncol, Madrid, Spain

[8] Hosp Univ Son Espases, Dept Med Oncol, Palma De Mallorca, Spain

[9] Hosp Basurto, Dept Med Oncol, Bilbao, Spain

[10] Hosp Univ Donostia, Med Oncol, San Sebastian, Spain

[11] Hosp Badalona Germans Trias & Pujol, Dept Med Oncol, Catalan Inst Oncol ICO Badalona, Badalona, Spain

[12] Hosp Xeral Calde Lugo, Dept Med Oncol, Lugo, Spain

[13] Hosp Son Llatzer, Dept Med Oncol, Palma De Mallorca, Spain

[14] Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain

[15] Hosp Univ La Princesa, Dept Med Oncol, Madrid, Spain

[16] Hosp Univ Virgen Macarena, Dept Med Oncol, Seville, Spain

[17] Hosp Santa Creu & Sant Pau, Dept Radiotherap Oncol, Barcelona, Spain

[18] Hosp Gen Univ Alicante, Dept Radiotherap Oncol, Alicante, Spain

[19] Hosp Univ Puerta de Hierro Majadahonda, Dept Radiotherap Oncol, Madrid, Spain

[20] Hosp Univ Puerta de Hierro Majadahonda, Med Oncol, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1461P

引用

页码：594 / 594

页数：1

共 50 条

[21] Final results of a Spanish Lung Cancer Group (SLCG) phase II study of paclitaxel (PAC) plus gemcitabine (GEM) in locally advanced and metastatic non-small cell lung cancer (NSCLC).
Isla, D
González-Larriba, JL
Felip, E
Camps, C
Artal, A
Carrato, A
Azagra, P
Alberola, V
Massutti, B
Rosell, R
ANNALS OF ONCOLOGY, 2000, 11 : 114 - 114
[22] Phase II trial of irinotecan plus cisplatin with concurrent thoracic radiotherapy (TRT) in patients with previously untreated locally advanced non-small cell lung cancer (NSCLC)
Fukuda, M.
Soda, H.
Nakamura, Y.
Fukuda, M.
Kinoshita, A.
Nagashima, S.
Nakano, H.
Yamaguchi, H.
Kohno, S.
Oka, M.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[23] A randomized phase II study of TS-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC): WJOG 5008L.
Seto, Takashi
Sasaki, Tomonari
Yamanaka, Takeharu
Kunitake, Naonobu
Shimizu, Junichi
Kodaira, Takeshi
Nishio, Makoto
Kozuka, Takuyo
Takahashi, Toshiaki
Harada, Hideyuki
Yoshimura, Naruo
Tsutsumi, Shinichi
Kitajima, Hiromoto
Kataoka, Masaaki
Nakagawa, Kazuhiko
Nishimura, Yasumasa
Nakanishi, Yoichi
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[24] A Phase II Study of S-1 (S) Plus Cisplatin (P) with Concurrent Thoracic Radiotherapy (TRT) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) West Japan Oncology Group (WJOG) 3706 Trial
Katakami, Nobuyuki
Kokubo, Masaki
Sawa, Toshiyuki
Tanaka, Masahiro
Seto, Takashi
Sasaki, Tomonari
Yamanaka, Takeharu
Ichinose, Yukito
Nishimura, Yasumasa
Nakagawa, Kazuhiko
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S372 - S372
[25] Concurrent chemoradiation with cisplatin and vinorelbine followed by consolidation with oral vinorelbine in locally advanced non-small cell lung cancer (NSCLC): the phase II CONCAVE study
Hughes, Brett G. M.
Ahern, Elizabeth
Lehman, Margot
Pratt, Gary
Dauth, Margaret
Pritchard, Wendy
Wockner, Leesa
Horwood, Keith
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (03) : 137 - 144
[26] A phase II trial of low-dose metronomic oral vinorelbine as salvage treatment in advanced non-small cell lung cancer (NSCLC)
Agelaki, S.
Kontopodis, E. D.
Kentepozidis, N.
Giassas, S.
Vamvakas, L.
Androulakis, N.
Kotsakis, K.
Sfakiotaki, G.
Mavroudis, D.
Georgoulias, V
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S448 - S448
[27] A phase II study of cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Interim analysis
Juan Vidal, Oscar
Vazquez-Estevez, Sergio
Giner, Vicente
Casal Rubio, Joaquin
Firvida, Jose-luis
Aparisi, Francisco
Munoz-Langa, Jose
Garcia Sanchez, Jose
Girones, Regina
Javier Perez, Francisco
Sanchez-Hernandez, Alfredo
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[28] A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L
Sasaki, Tomonari
Seto, Takashi
Yamanaka, Takeharu
Kunitake, Naonobu
Shimizu, Junichi
Kodaira, Takeshi
Nishio, Makoto
Kozuka, Takuyo
Takahashi, Toshiaki
Harada, Hideyuki
Yoshimura, Naruo
Tsutsumi, Shinichi
Kitajima, Hiromoto
Kataoka, Masaaki
Ichinose, Yukito
Nakagawa, Kazuhiko
Nishimura, Yasumasa
Yamamoto, Nobuyuki
Nakanishi, Yoichi
BRITISH JOURNAL OF CANCER, 2018, 119 (06) : 675 - 682
[29] A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L
Tomonari Sasaki
Takashi Seto
Takeharu Yamanaka
Naonobu Kunitake
Junichi Shimizu
Takeshi Kodaira
Makoto Nishio
Takuyo Kozuka
Toshiaki Takahashi
Hideyuki Harada
Naruo Yoshimura
Shinichi Tsutsumi
Hiromoto Kitajima
Masaaki Kataoka
Yukito Ichinose
Kazuhiko Nakagawa
Yasumasa Nishimura
Nobuyuki Yamamoto
Yoichi Nakanishi
British Journal of Cancer, 2018, 119 : 675 - 682
[30] A randomized phase II trial of concurrent chemoradiation of oral vinorelbine and two doses of radiotherapy, 60 and 66 Gy, in local-regionally advanced non-small cell lung cancer (LA-NSCLC).
Hansen, Olfred
Knap, Marianne
Khalil, Azza
Nyhus, Christa Haugaard
McCulloch, Tine
Holm, Bente
Brink, Carsten
Hoffmann, Lone
Schytte, Tine
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

← 1 2 3 4 5 →